* This information was provided by Atmofizer Technologies Inc and may contain additional information outside the scope of this Claim Verification.
ATMOFIZER ONE, ATMOFIZER 2000
Reduces 99.99% of airborne viruses and bacteria in treated air. See UL Verify for specific organisms.
Organisms used during the bacterial inoculation: Staphylococcus epidermidis (ATCC 14190), Klebsiella aerogenes (vegetative bacterium), MS2 bacteriophage (naked RNA virus), Φ6 bacteriophage (enveloped virus). Organism used during viral inoculation: Escherichia coli bacteriophage Phi-X174 (ATCC 13706-B1) Bioaerosols were aerosolized into a sealed 1m³ environmental chamber containing the assessed product. AGI impingers were used to determine chamber bioaerosol concentrations at pre-determined sampling times. All impinger samples were serially diluted, plated and enumerated in triplicate to yield viable bioaerosol concentration at each sampling point and time. Chamber control trial data was subtracted from the assessed product trial data to yield net LOG reduction in the chamber for viable bioaerosol concentration. The average net LOG reduction was measured after 120, and 180 minutes of operation.
UL Verification is an objective, science-based assessment that confirms the accuracy of marketing claims. Our independent assessment process scrutinizes the validity of specific advertising or promotional statements, giving you a way to separate verified fact from fiction.